{Reference Type}: Journal Article
{Title}: Vascular senescence and ageing: a role for the MEOX proteins in promoting endothelial dysfunction.
{Author}: Northcott JM;Czubryt MP;Wigle JT;
{Journal}: Can J Physiol Pharmacol
{Volume}: 95
{Issue}: 10
{Year}: Oct 2017
{Factor}: 2.245
{DOI}: 10.1139/cjpp-2017-0149
{Abstract}: In the vascular system, ageing is accompanied by the accrual of senescent cells and is associated with an increased risk of vascular disease. Endothelial cell (EC) dysfunction is a hallmark of vascular disease and is characterized by decreased angiogenic potential, reduced nitric oxide bioavailability, impaired vasodilation, increased production of ROS, and enhanced inflammation. In ECs, the major producer of nitric oxide is the endothelial nitric oxide synthase (eNOS) enzyme that is encoded by the NOS3 gene. NOS3/eNOS function is tightly regulated at both the transcriptional and post-transcriptional levels to maintain normal vascular function. A key transcriptional regulator of eNOS expression is p53, which has been shown to play a central role in mediating cellular senescence and thereby vascular dysfunction. Herein, we show that, in ECs, the MEOX homeodomain transcription factors decrease the expression of genes involved in angiogenesis, repress eNOS expression at the mRNA and protein levels, and increase the expression of p53. These findings support a role for the MEOX proteins in promoting endothelial dysfunction.